Kathmandu [Nepal], May 19 (ANI): After confirming two variants of coronavirus, Nepal on Tuesday confirmed that there were cases of third variant B.1.617.2 in the country.
Beijing [China], May 18 (ANI): Chinese infectious disease specialist has warned that slow global COVID-19 vaccine roll-out risks allowing new variants to emerge as the world continues to combat the pandemic.
New Delhi [India], May 18 (ANI): Bharat Biotech is set to begin the phase II and III clinical trials for COVID-19 vaccine Covaxin in children in the age group of 2 to 18 years in the next 10-12 days, informed VK Paul, Member (Health), Niti Aayog on Tuesday.
New Delhi [India], May 18 (ANI/SRV Media): Introducing Advince, a one-stop platform for all financial, accounting, auditing, taxation, and advisory services. Its extensive experience deals in various government agencies such as Income Tax, Service Tax, GST, Professional Tax, STPI, SEZ, RBI,
Peshawar [Pakistan], May 18 (ANI): Pakistan has officially denied that the B.1.617 variant of the coronavirus has entered the country, despite experts noting that it does not have specialised kits to detect the highly contagious COVID-19 mutation.
New Delhi [India] May 18, (ANI): The Pfizer/BioNTech and Moderna coronavirus vaccines appear to protect against COVID variants B.1.617 and B.1.618 first identified in India, researchers have reported in a new pre-print paper, which has not yet been peer-reviewed, CNN reported.
New Delhi [India], May 17 (ANI): The DRDO's new anti-COVID drug, 2-DG, reduces a patient's average recovery time by two and a half days and oxygen demand by upto 40 per cent, the union health ministry informed on Monday.
Vadodara (Gujarat) [India], May 17 (ANI): Railways has crossed the milestone of delivering more than 10,300 MT of liquid medical oxygen (LMO) via 160 Oxygen Expresses to 13 states, in slightly over 23 days of time.
New Delhi [India], May 17 (ANI): The Defence Research and Development Organisation's (DRDO) new anti-COVID drug 2-DG should work against various strains of the COVID-19 virus, DRDO chairperson Dr G Satheesh Reddy said on Monday.
New Delhi [India], May 17 (ANI): After the first batch of anti-COVID drug 2-DG developed by DRDO was released by Defence Minister Rajnath Singh here, it will be available only to AIIMS, Armed Forces Hospitals, DRDO hospitals and other places in need. While the drug shall be made available to
Dehradun (Uttarakhand) [India], May 17 (ANI): At least 16 variants of coronavirus have been found active in Uttarakhand, according to a report of samples sent by the state government for genome sequencing for the virus.
New Delhi [India], May 17 (ANI): Union Health Minister Dr Harsh Vardhan on Monday said that the recovery time from COVID-19 infection and oxygen dependency will be reduced by anti-COVID drug 2-deoxy-D-glucose (2-DG) developed by the Defence Research and Development Organisation (DRDO).